Zopiclone misuse: an update from Dublin

References

• Lader M. Zopiclone: is there any dependence and abuse potential?. J Neurol 1997, Suppl. 1: S18–S22
   Google Scholar
• Thakore J, Dinan T G. Physical dependence following zopiclone usage: a case report. Human Psychopharmacol 1992; 7: 143–145
   Google Scholar
• Bianchi M, Musch B. Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena. Int Clin Psychopharmacol 1990; 5(Suppl. 2)139–145
   PubMedGoogle Scholar
• Hajak G. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years of clinical experience. Drug Safety 1999; 21: 457–469
   PubMed Web of Science ®Google Scholar
• Hajak G, Muller W E, Wittchen H U, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003; 98: 1371–1378
   PubMed Web of Science ®Google Scholar
• Sikdar S, Ruben S M. Zopiclone abuse among polydrug users (letter). Addiction 1996; 91: 285–291
   PubMedGoogle Scholar
• Ayonrinde O, Sampson E. Physical dependence on zopiclone: risk of dependence maybe greater in those with dependent personalities (Letter). BMJ 1998; 317: 146
   PubMedGoogle Scholar
• Jones I R, Sullivan G. Physical dependence on zopiclone: case reports. BMJ 1998; 316(7125)117
   PubMedGoogle Scholar
• Rooney S, O'Connor J J. Zopiclone, a current drug of misuse. (Letter) Addiction 1999; 93: 925
   Google Scholar
• Rhone-Poulenc Rorer. Zopiclone. Pharmacovigilance data, update of 28 February 1993
   Google Scholar
• Rhone-Poulenc Rorer. Zopiclone. Pharmacovigilance data, 1 March 1993 – 28 February 1994
   Google Scholar
• Sikdar S. Physical dependence on zopiclone. Prescribing this drug to addicts may give rise to iatrogenic drug misuse. BMJ 1998; 317: 146
   PubMedGoogle Scholar
• Inman W, Kubota K, Pearce G, Wilton L. PEM Report no. 10. Zopiclone. Pharmacoepidemiol Drug Safety 1993; 2: 499–521
   Google Scholar
• Rush C R. Behavioural pharmacology of zolpidem relative to benzodiazepines; a review. Pharmacol Biochem Behav 1998; 61: 253–269
   PubMed Web of Science ®Google Scholar
• Darcourt G, Pringuey D, Salliere D, Lavoisy J. The safety and tolerability of zolpidem – an update. J Psychopharmacol 1999; 13: 81–93
   PubMed Web of Science ®Google Scholar
• Soyka M, Bottlender R, Moller H J. Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry 2000; 33: 138–141
   PubMed Web of Science ®Google Scholar
• Alvarez M D. Zopiclona: estudio de postcomercialization en Espana (Zopiclone: postmarketing study in Spain). Psiquis 1994; 15: 17–24
   Google Scholar
• Soldatos C R, Dikeos D G, Whitehead A. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 1994; 14: 287–303
   Google Scholar
• Clee W B, McBride A J, Sullivan G. Warning about zopiclone misuse. Addiction 1996; 91: 1389–1390
   PubMedGoogle Scholar
• Ross H E. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 1993; 88: 209–218
   PubMed Web of Science ®Google Scholar
• Busto U E, Romach M K, Seller E M. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. J Clin Psychopharmacol 1996; 16: 51–57
   PubMed Web of Science ®Google Scholar
• Martinez-Cano H, de Iceta de Gauna M, Vela-Bueno A, Witchen H U. DSM-III-R co-morbidity in benzodiazepine dependence. Addiction 1999; 94: 97–107
   PubMedGoogle Scholar
• Jaffe J H, Bloor R, Crome I, Carr M, Alam F, Simmoms A, Meyer R E. A postmarketing study of relative abuse liability of hypnotic sedative drugs. (Report). Addiction 2004; 99: 165–173
   PubMed Web of Science ®Google Scholar
• Bechelli A, Naras F P, Pierangelo S A. Evaluation of zopiclone physical dependence liability in normal volunteers. Pharmacology 1983; 27(Suppl. 2)228–234
   PubMedGoogle Scholar
• Musch B, Maillard F. Zopiclone the third generation hypnotic: a clinical overview. Int Clin Psychopharmacol 1990; 5(Suppl. 2)147–158
   PubMedGoogle Scholar
• Ruben S, Morrison C L. Temazepam misuse in a group of injecting users. Br J Addict 1992; 87: 1387–1392
   PubMedGoogle Scholar